Alzheimer disease (AD) is a frequent and devastating neurodegenerative disease in
humans, but still no curative treatment has been developed. Although many explicative …

Alzheimer's disease (AD) is a neurodegenerative disease with major clinical hallmarks of
memory loss, dementia, and cognitive impairment. Neuroinflammation is involved in the …

Amyloid-β (Aβ) pathology is known to promote chronic inflammatory responses in the brain.
It was thought previously that Aβ is only associated with Alzheimer's disease and Down …

Alzheimer's disease (AD) is a neurodegenerative disorder that usually develops slowly and
progressively worsens over time. Although there has been increasing research interest in …

A growing body of research suggests that astrocytes play roles as contributors to the
pathophysiology of Alzheimer's disease (AD). Several lines of evidence propose that …

Alzheimer's disease is a neurodegenerative disease characterized by deposition of
extracellular amyloid‐β, intracellular neurofibrillary tangles, and loss of cortical neurons …

Alzheimer's disease (AD) is a chronic and fatal disease, in which neuronal damage at its late
stage cannot be easily reversed. Because AD progression is caused by multiple factors …

Data from animal models and Alzheimer's disease (AD) subjects provide clear evidence for
an activation of inflammatory pathways during the pathogenetic course of such illness …

Increased production of amyloid β-peptide (Aβ) and altered processing of tau in Alzheimer's
disease (AD) are associated with synaptic dysfunction, neuronal death and cognitive and …

The neuroinflammatory hypothesis of Alzheimer's disease (AD) was proposed more than 30
years ago. The involvement of the two main types of glial cells microglia and astrocytes, in …